Literature DB >> 26261666

Richter transformation with c-MYC overexpression: report of three cases.

Ling Wang1, Azadeh Aghel1, Brandon Peterson2, Jessica Wang-Rodriguez3, Huan-You Wang1, Xianfeng Frank Zhao3.   

Abstract

Pathogenesis of Richter transformation (RT) or Richter syndrome (RS) of chronic lymphocytic leukemia (CLL) is still largely unknown. Increasing evidences show that c-MYC may play a role in the development of RS. Here we report three cases of RS with overexpression of c-MYC. The first case was a 78-year-old male who initially presented with CLL and then developed diffuse lymphadenopathy and ascites shortly after. Ascites cytology showed a population of large lymphoid cells positive for MYC (8q24) rearrangement by fluorescence in situ hybridization (FISH) and overexpression of c-MYC by immunohistochemistry (IHC). The second case was a 66-year-old male presented with rapidly enlarging lymph nodes and pleural effusion after a long history of CLL. Biopsy showed large B-cells positive for c-MYC overexpression and high Ki-67 proliferation index (80-90%). The third case was a 62-year-old female with CLL who presented for lobectomy for lung adenocarcinoma. Interestingly, along with the carcinoma, large B-cell lymphoma was incidentally found which had the same immunophenotype as the CLL. FISH analysis revealed gain of c-MYC at 8q and IHC showed increased c-MYC expression. This study supports that c-MYC plays a critical role in RS.

Entities:  

Keywords:  Chronic lymphocytic leukemia/small lymphocytic lymphoma; MYC; Richter syndrome; diffuse large B-cell lymphoma

Mesh:

Substances:

Year:  2015        PMID: 26261666      PMCID: PMC4526000     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

1.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.

Authors:  Izidore S Lossos; Ash A Alizadeh; Maximilian Diehn; Roger Warnke; Yvonne Thorstenson; Peter J Oefner; Patrick O Brown; David Botstein; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus.

Authors:  Teresa Vela-Chávez; Patrick Adam; Marcus Kremer; Karin Bink; Christopher M Bacon; Geetha Menon; Judith A Ferry; Falko Fend; Elaine S Jaffe; Leticia Quintanilla-Martínez
Journal:  Leuk Lymphoma       Date:  2011-02-01

Review 3.  Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features.

Authors:  Suyang Hao; Warren Sanger; Mihaela Onciu; Raymond Lai; Ellen J Schlette; L Jeffrey Medeiros
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

4.  The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation.

Authors:  Davide Rossi; Valeria Spina; Clara Deambrogi; Silvia Rasi; Luca Laurenti; Kostas Stamatopoulos; Luca Arcaini; Marco Lucioni; Gabrielle B Rocque; Zijun Y Xu-Monette; Carlo Visco; Julie Chang; Ekaterina Chigrinova; Francesco Forconi; Roberto Marasca; Caroline Besson; Theodora Papadaki; Marco Paulli; Luigi M Larocca; Stefano A Pileri; Valter Gattei; Francesco Bertoni; Robin Foà; Ken H Young; Gianluca Gaidano
Journal:  Blood       Date:  2011-01-25       Impact factor: 22.113

5.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

Authors:  B D Cheson; J M Bennett; M Grever; N Kay; M J Keating; S O'Brien; K R Rai
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

6.  How we treat Richter syndrome.

Authors:  Sameer A Parikh; Neil E Kay; Tait D Shanafelt
Journal:  Blood       Date:  2014-01-13       Impact factor: 22.113

Review 7.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

8.  Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia.

Authors:  F Cobo; A Martínez; M Pinyol; L Hernández; M Gómez; S Beá; J Esteve; M Rozman; F Bosch; A López-Guillermo; E Montserrat; E Campo
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

9.  Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.

Authors:  Philip Kuriakose; Nusrat Perveen; Koichi Maeda; Anne Wiktor; Daniel L Van Dyke
Journal:  Cancer Genet Cytogenet       Date:  2004-04-15

10.  Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Nathalie A Johnson; Graham W Slack; Kerry J Savage; Joseph M Connors; Susana Ben-Neriah; Sanja Rogic; David W Scott; King L Tan; Christian Steidl; Laurie H Sehn; Wing C Chan; Javeed Iqbal; Paul N Meyer; Georg Lenz; George Wright; Lisa M Rimsza; Carlo Valentino; Patrick Brunhoeber; Thomas M Grogan; Rita M Braziel; James R Cook; Raymond R Tubbs; Dennis D Weisenburger; Elias Campo; Andreas Rosenwald; German Ott; Jan Delabie; Christina Holcroft; Elaine S Jaffe; Louis M Staudt; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

View more
  1 in total

1.  The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia.

Authors:  Yan Li; Shimin Hu; Sa A Wang; Shaoying Li; Yang O Huh; Zhenya Tang; L Jeffrey Medeiros; Guilin Tang
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.